Mountaineer Partners Management, LLC Bausch Health Companies Inc. Transaction History

Mountaineer Partners Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $9.15 Million - $11.8 Million	-423,695 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $785,335 - $990,546	34,145 Added 8.77%	423,695 $11.7 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $9.75 Million - $11.7 Million	389,550 New	389,550 $10.8 Million
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $10.4 Million - $16.8 Million	-487,700 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $1.34 Million - $1.85 Million	87,700 Added 21.93%	487,700 $10.1 Million
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $5.95 Million - $8.05 Million	400,000 New	400,000 $6.22 Million

269

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.35B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Mountaineer Partners Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Mountaineer Partners Management, LLC with notifications on news.